NCT02014142 A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma Status COMPLETED Phase PHASE2
NCT02003547 A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02003534 A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension Status COMPLETED Phase PHASE4
NCT02003391 Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure Status COMPLETED Phase PHASE4
NCT01999348 A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting Status COMPLETED Phase N/A
NCT01995136 Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma Status COMPLETED Phase PHASE4
NCT01987323 Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension Status COMPLETED Phase PHASE1/PHASE2
NCT01979913 An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More Status COMPLETED Phase PHASE4
NCT01978600 Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE4
NCT01976624 Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea Status COMPLETED Phase N/A
NCT01975714 Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study Status COMPLETED Phase PHASE4
NCT01943721 A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE1
NCT01937312 Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue Status COMPLETED Phase PHASE4
NCT01937299 Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® Status COMPLETED Phase PHASE4
NCT01936389 A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma Status COMPLETED Phase PHASE2
NCT01927406 The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. Status WITHDRAWN Phase PHASE4
NCT01915940 Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE2
NCT01896180 Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost Status COMPLETED Phase PHASE2
NCT01895972 Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT Status COMPLETED Phase PHASE3